Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Post-COVID Respiratory Sequelae in COPD: Mucus Plugging, Infectious Complications, and Risk-Stratified Follow-Up.
Florina Cristiana Lucaciu1,2,3, Norbert Wellmann1,2,4, Ana Maria Mihai1,2,3
1Doctoral School, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Patients with chronic obstructive pulmonary disease (COPD) face increased risks from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including mucus plugs and secondary infections. Careful monitoring post-discharge is crucial for managing respiratory sequelae.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Critical Care
Background:
- Chronic obstructive pulmonary disease (COPD) involves mucus dysfunction, inflammation, and impaired immunity.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection exacerbates these underlying lung conditions.
- Understanding the interplay between COPD and COVID-19 is critical for patient outcomes.
Purpose of the Study:
- To review the impact of SARS-CoV-2 infection in COPD patients.
- To synthesize evidence on respiratory sequelae and complications.
- To identify critical periods for intervention.
Main Methods:
- Focused narrative review of clinical, experimental, and consensus evidence (2020-2025).
- Qualitative synthesis prioritizing cohort studies, meta-analyses, and mechanism-focused studies.
- Focused on outcomes related to mucus obstruction, infections, sepsis, and exacerbations.
Main Results:
- Mucus plugs are common in COPD (41-67%) and linked to poor outcomes.
- Secondary bacterial infections (14-18%) and sepsis are significant concerns, especially in severe COVID-19.
- Increased risk of COPD exacerbations post-discharge, peaking within 30 days of severe disease.
- Persistent dyspnea and reduced diffusing capacity for carbon monoxide (DLCO) indicate ARDS-related injury.
Conclusions:
- Post-COVID respiratory sequelae in COPD result from mucus, immune, and infectious complications.
- The first month after hospital discharge is critical for risk stratification and follow-up.
- Targeted interventions are needed to mitigate long-term respiratory decline.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

